Steve Schonfeld’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Steve Schonfeld’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-93,428	Closed	-$927K	–	3047
2021 Q4	$927K	Sell	93,428 -145,397	-61%	-$1.45M	0.01%	981
2021 Q3	$2.36M	Buy	238,825 +196,946	+470%	+$1.93M	0.02%	659
2021 Q2	$411K	Buy	41,879 +21,879	+109%	+$213K	﹤0.01%	1292
2021 Q1	$194K	Buy	+20,000	New	+$196K	﹤0.01%	1524

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return

CGC

Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $1.94B AUM 48.68% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCMH

Oxbow Capital Management (HK) Hong Kong $355M AUM 567.47% 1-Year Est. Return

Steve Schonfeld's GRNA Position: Q1 2022 in Review

Steve Schonfeld sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2022, closing a stake of 93,428 shares — an estimated $927K sold.

Steve Schonfeld first reported a position in GRNA in Q1 2021 and held it in 4 quarters. The position peaked at $2.36M in Q3 2021. 39 funds tracked by Wall St. Rank hold GRNA as of Q1 2022.

Steve Schonfeld reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2022 after selling out during the quarter.
Steve Schonfeld sold 93,428 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2022, an estimated $927K.
Steve Schonfeld first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 4 quarters.
Steve Schonfeld's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $2.36M in Q3 2021.
39 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2022, filed 16 May 2022.